Nonredundant Roles of Platelet Glycoprotein VI and Integrin αIIbβ3 in Fibrin-Mediated Microthrombus Formation.


Journal

Arteriosclerosis, thrombosis, and vascular biology
ISSN: 1524-4636
Titre abrégé: Arterioscler Thromb Vasc Biol
Pays: United States
ID NLM: 9505803

Informations de publication

Date de publication:
02 2021
Historique:
pubmed: 4 12 2020
medline: 2 6 2021
entrez: 3 12 2020
Statut: ppublish

Résumé

Fibrin is considered to strengthen thrombus formation via integrin αIIbβ3, but recent findings indicate that fibrin can also act as ligand for platelet glycoprotein VI. Approach and Results: To investigate the thrombus-forming potential of fibrin and the roles of platelet receptors herein, we generated a range of immobilized fibrin surfaces, some of which were cross-linked with factor XIIIa and contained VWF-BP (von Willebrand factor-binding peptide). Multicolor microfluidics assays with whole-blood flowed at high shear rate (1000 s Together, these results indicate that fibrin fibers, regardless of their way of formation, act as a consolidating surface in microthrombus formation via nonredundant roles of platelet glycoprotein VI and integrin αIIbβ3 through signaling via Syk and low-level Ca

Identifiants

pubmed: 33267658
doi: 10.1161/ATVBAHA.120.314641
doi:

Substances chimiques

Platelet Glycoprotein GPIIb-IIIa Complex 0
Platelet Membrane Glycoproteins 0
platelet membrane glycoprotein VI 0
Fibrin 9001-31-4
SYK protein, human EC 2.7.10.2
Syk Kinase EC 2.7.10.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e97-e111

Subventions

Organisme : Wellcome Trust
ID : 204951/Z/16/Z
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/03/003/15571
Pays : United Kingdom

Auteurs

Gina Perrella (G)

Department of Biochemistry, CARIM, Maastricht University, the Netherlands (G.P., J.H., I.P., F.S., P.E.J.v.d.M., R.A.S.A., S.P.W., J.W.M.H.).
Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, United Kingdom (G.P., M.T., S.P.W.).

Jingnan Huang (J)

Department of Biochemistry, CARIM, Maastricht University, the Netherlands (G.P., J.H., I.P., F.S., P.E.J.v.d.M., R.A.S.A., S.P.W., J.W.M.H.).
ISAS Institute, Dortmund, DE (J.H.).

Isabella Provenzale (I)

Department of Biochemistry, CARIM, Maastricht University, the Netherlands (G.P., J.H., I.P., F.S., P.E.J.v.d.M., R.A.S.A., S.P.W., J.W.M.H.).

Frauke Swieringa (F)

Department of Biochemistry, CARIM, Maastricht University, the Netherlands (G.P., J.H., I.P., F.S., P.E.J.v.d.M., R.A.S.A., S.P.W., J.W.M.H.).

Floor C J I Heubel-Moenen (FCJI)

Department of Haematology-Internal Medicine, MUMC+, Maastricht, the Netherlands (F.C.J.I.H.-M.).

Richard W Farndale (RW)

Department of Biochemistry, University of Cambridge, United Kingdom (R.W.F.).

Mark Roest (M)

Synapse Research Institute, Maastricht, the Netherlands (M.R.).

Paola E J van der Meijden (PEJ)

Department of Biochemistry, CARIM, Maastricht University, the Netherlands (G.P., J.H., I.P., F.S., P.E.J.v.d.M., R.A.S.A., S.P.W., J.W.M.H.).

Mark Thomas (M)

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, United Kingdom (G.P., M.T., S.P.W.).

Robert A S Ariëns (RAS)

Department of Biochemistry, CARIM, Maastricht University, the Netherlands (G.P., J.H., I.P., F.S., P.E.J.v.d.M., R.A.S.A., S.P.W., J.W.M.H.).
Department of Discovery and Translational Science, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (R.A.S.A.).

Martine Jandrot-Perrus (M)

UMR S1148, Laboratory for Vascular Translational Science, INSERM, University Paris Diderot, France (M.J.-P.).

Steve P Watson (SP)

Department of Biochemistry, CARIM, Maastricht University, the Netherlands (G.P., J.H., I.P., F.S., P.E.J.v.d.M., R.A.S.A., S.P.W., J.W.M.H.).
Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, United Kingdom (G.P., M.T., S.P.W.).
COMPARE, The Universities of Birmingham and Nottingham, the Midlands, United Kingdom (S.P.W.).

Johan W M Heemskerk (JWM)

Department of Biochemistry, CARIM, Maastricht University, the Netherlands (G.P., J.H., I.P., F.S., P.E.J.v.d.M., R.A.S.A., S.P.W., J.W.M.H.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH